| Date Filed | Type | Description |
| 10/03/2023 |
4
| Chen Hubert C (See remarks) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 2,593 shares
@ $0.662, valued at
$1.7k
Exercised 7,500 restricted stock units
@ $0 |
|
| 10/03/2023 |
4
| Riley Antony A (CFO) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 3,241 shares
@ $0.662, valued at
$2.1k
Exercised 9,375 restricted stock units
@ $0 |
|
| 10/03/2023 |
4
| Wagner Paul A. (See Remarks) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 2,453 shares
@ $0.662, valued at
$1.6k
Exercised 31,250 restricted stock units
@ $0 |
|
| 08/02/2023 |
4
| Kornfeld Steven (Director) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Granted 99,009 shares
@ $1.01, valued at
$100k
|
|
| 08/02/2023 |
4
| Williams Donald Allen (Director) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Granted 59,405 shares
@ $1.01, valued at
$60k
|
|
| 08/02/2023 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Granted 148,514 shares
@ $1.01, valued at
$150k
|
|
| 08/02/2023 |
4
| Chen Hubert C (See remarks) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Granted 74,257 shares
@ $1.01, valued at
$75k
|
|
| 08/02/2023 |
4
| Riley Antony A (CFO) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Granted 148,514 shares
@ $1.01, valued at
$150k
|
|
| 08/02/2023 |
4
| Wagner Paul A. (See Remarks) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Granted 247,524 shares
@ $1.01, valued at
$250k
|
|
| 07/05/2023 |
4
| Chen Hubert C (See remarks) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 2,593 shares
@ $1.04, valued at
$2.7k
Exercised 7,500 restricted stock units
@ $0 |
|
| 07/05/2023 |
4
| Riley Antony A (CFO) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 3,241 shares
@ $1.04, valued at
$3.4k
Exercised 9,375 restricted stock units
@ $0 |
|
| 07/05/2023 |
4
| Wagner Paul A. (See Remarks) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 2,453 shares
@ $1.04, valued at
$2.6k
Exercised 31,250 restricted stock units
@ $0 |
|
| 04/04/2023 |
4
| Wagner Paul A. (See Remarks) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 11,046 shares
@ $1.01, valued at
$11.2k
Exercised 31,250 restricted stock units
@ $0 |
|
| 04/04/2023 |
4
| Riley Antony A (CFO) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 3,241 shares
@ $1.01, valued at
$3.3k
Exercised 9,375 restricted stock units
@ $0 |
|
| 04/04/2023 |
4
| Chen Hubert C (See remarks) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 2,593 shares
@ $1.01, valued at
$2.6k
Exercised 7,500 restricted stock units
@ $0 |
|
| 03/23/2023 |
4
| Wagner Paul A. (See Remarks) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Granted 500,000 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| Riley Antony A (CFO) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Granted 150,000 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| Chen Hubert C (See remarks) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Granted 120,000 restricted stock units
@ $0 |
|
| 01/12/2023 |
4
| GRYSKA DAVID W (Director) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.02, valued at
$51k
|
|
| 01/12/2023 |
3
| GRYSKA DAVID W (Director) has filed a Form 3 on Forte Biosciences, Inc. |
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/14/2022 |
4
| Brun Scott C. (Director) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1, valued at
$50k
|
|
| 11/14/2022 |
3
| Brun Scott C. (Director) has filed a Form 3 on Forte Biosciences, Inc. |
| 06/08/2022 |
4
| Chen Hubert C (See remarks) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Granted 250,000 options to buy
@ $1.3, valued at
$325k
|
|
| 06/08/2022 |
3
| Chen Hubert C (See remarks) has filed a Form 3 on Forte Biosciences, Inc. |
| 06/02/2022 |
4
| Williams Donald Allen (Director) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.27, valued at
$31.8k
|
|
| 06/02/2022 |
4
| Walker Patricia S (Director) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.27, valued at
$31.8k
|
|
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| FINCK BARBARA K (Director) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.27, valued at
$31.8k
|
|
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| Doberstein Stephen K (Director) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Granted 25,000 options to buy
@ $1.27, valued at
$31.8k
|
|
| 05/16/2022 |
4
| Doberstein Stephen K (Director) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.18, valued at
$59k
|
|
| 05/16/2022 |
3
| Doberstein Stephen K (Director) has filed a Form 3 on Forte Biosciences, Inc. |
| 05/16/2022 |
4
| Wagner Paul A. (See Remarks) has filed a Form 4 on Forte Biosciences, Inc.|
Txns:
| Disposed/sold 40,000 options to buy
@ $39.66, valued at
$1.6M
|
|
|